DNA synthesis is vital to several processes in biopharmaceutical innovation, including the development of gene therapies, CRISPR gene editing, antisense oligonucleotides and RNA therapies. The need ...

DNA is the raw material of modern medicine yet is the only part of drug development not accessible at the lab bench. DNA synthesis, the first step in most biological workflows including gene synthesis ...

"Complex chemical processes are essential for making DNA." This long-held assumption in the field of biotechnology has been overturned by a Korean research team. A KAIST research team has developed ...

This breakthrough transforms the building of synthetic DNA from a chemical process to an electrical one.

A new DNA synthesis method that relies on temperature rather than the endless replacement of reagents and molecular building blocks could prove a vital innovation in the field of biocomputing. A ...

Demand for synthetic DNA is growing across multiple industries including cell and gene therapy development and biomanufacturing. Coupled with that growth is a need for genetic constructs that can, in ...

EMERYVILLE, Calif.--(BUSINESS WIRE)--Ansa Biotechnologies, Inc., the trusted partner for complex DNA synthesis, today announced that it can now deliver its Ansa Clonal DNA product in lengths up to 5 ...

Genetic medicines such as cell and gene therapies and mRNA vaccines offer extraordinary promise for treating a variety of diseases, including genetic disorders, cancer, and autoimmune diseases. These ...

The "DNA and Gene Cloning Services - Market Insights, Competitive Landscape, Forecast - 2034" has been added to ResearchAndMarkets.com's offering. The global DNA and gene cloning services market was ...

IDT and Ansa expand access to complex DNA constructs up to 50 kb through integrated ordering, supporting synthetic biology and gene editing research.